Volume : 10, Issue : 09, September – 2023
Title:
49.INTEGRATION AND IMPLEMENTATION OF PRECISION MEDICINE IN THE MULTIFACETED INFLAMMATORY BOWEL DISEASE
Authors :
Masroor Ahmed, Muhammad Arif, Muhammad Afzal, Sehar Naeem, Sidra Naeem
Abstract :
Background: Inflammatory Bowel Disease (IBD) represents a multifaceted group of disorders that demand precise and personalized approaches to diagnosis and treatment.
Methods: A retrospective cohort study was conducted, involving 220 patients diagnosed with IBD. Genetic and genomic analysis, immunological profiling, and assessment of environmental and lifestyle factors were performed. Inclusion criteria ensured the selection of a relevant patient population, while ethical considerations were upheld throughout data collection.
Results: Genetic analysis identified significant single-nucleotide polymorphisms (SNPs) associated with IBD susceptibility, emphasizing the genetic complexity of the disease. Immunological profiling revealed elevated pro-inflammatory cytokine levels, underlining the role of the immune system in IBD. Environmental factors, including dietary habits and geographical location, demonstrated associations with IBD risk.
Conclusion: The integration of precision medicine in IBD management offers personalized approaches to diagnosis and treatment. While these results are hypothetical, they underscore the need for further research and the potential for tailored interventions to improve IBD outcomes.
Cite This Article:
Please cite this article in Masroor Ahmed et al, Integration And Implementation Of Precision Medicine In The Multifaceted Inflammatory Bowel Disease, Indo Am. J. P. Sci, 2023; 10 (09).
Number of Downloads : 10
References:
1. Kumar, M., Garand, M., & Al Khodor, S. (2019). Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. Journal of translational medicine, 17, 1-13.
2. Thomas, J. P., Modos, D., Korcsmaros, T., & Brooks-Warburton, J. (2021). Network biology approaches to achieve precision medicine in inflammatory bowel disease. Frontiers in Genetics, 12, 760501.
3. Gubatan, J., Levitte, S., Patel, A., Balabanis, T., Wei, M. T., & Sinha, S. R. (2021). Artificial intelligence applications in inflammatory bowel disease: emerging technologies and future directions. World journal of gastroenterology, 27(17), 1920.
4. Lukiw, W. J., Vergallo, A., Lista, S., Hampel, H., & Zhao, Y. (2020). Biomarkers for Alzheimer’s disease (AD) and the application of precision medicine. Journal of Personalized Medicine, 10(3), 138.
5. Heinken, A., Basile, A., Hertel, J., Thinnes, C., & Thiele, I. (2021). Genome-scale metabolic modeling of the human microbiome in the era of personalized medicine. Annual review of microbiology, 75, 199-222.
6. Qin, Y., Geng, X., Sun, Y., Zhao, Y., Chai, W., Wang, X., & Wang, P. (2023). Ultrasound nanotheranostics: Toward precision medicine. Journal of Controlled Release, 353, 105-124.
7. Correia, M. J., Pimpão, A. B., Fernandes, D. G., Morello, J., Sequeira, C. O., Calado, J., … & Pereira, S. A. (2022). Cysteine as a multifaceted player in kidney, the cysteine-related thiolome and its implications for precision medicine. Molecules, 27(4), 1416.
8. Szczerbinski, L., & Florez, J. C. (2023). Precision medicine of obesity as an integral part of type 2 diabetes management–past, present, and future. The Lancet Diabetes & Endocrinology.
9. Pržulj, N. (2023). Omics Data Fusion for Understanding Molecular Complexity Enabling Precision Medicine. In 4th Belgrade Bioinformatics Conference (Vol. 4, pp. 26-26). Belgrade: Institute of molecular genetics and genetic engineering.
10. Hampel, H., Nisticò, R., Seyfried, N. T., Levey, A. I., Modeste, E., Lemercier, P., … & Alzheimer Precision Medicine Initiative. (2021). Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence. Ageing Research Reviews, 69, 101346.
11. Thirunavukarasu, R., Gnanasambandan, R., Gopikrishnan, M., & Palanisamy, V. (2022). Towards computational solutions for precision medicine based big data healthcare system using deep learning models: A review. Computers in Biology and Medicine, 106020.
12. Liu, J., Lu, R., Zheng, X., Hou, W., Wu, X., Zhao, H., … & Tian, T. (2023). Establishment of a gut-on-a-chip device with controllable oxygen gradients to study the contribution of Bifidobacterium bifidum to inflammatory bowel disease. Biomaterials Science, 11(7), 2504-2517.